在四个欧洲国家比较长效布普伦诺芬治疗buvidal的实施情况
Benjamin Rolland1, Catriona Matheson2, Ari Kaski3
1Service Universitaire d'Addictologie de Lyon (SUAL), Hospices Civils de Lyon, CH Le Vinatier, Lyon, France.
Expert opinion on drug delivery
|June 20, 2024
概括
布维达尔 (Buvidal) 是一种储存布普伦诺芬的药物,在欧洲各地的吸收中显示出显著的国家差异. 由于监管和护理系统因素,实施情况有所不同,这会影响阿片类药物激动剂治疗的可获得性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 布维达尔是欧洲唯一可用的存储布普伦诺芬配方.
- 它的引入需要对阿片类药物激动剂治疗 (OAT) 和医疗保健系统的国家监管框架进行潜在的调整.
研究的目的:
- 为了比较国家实施和传播布维达尔在欧洲各国.
- 分析监管和护理系统结构对OAT.Buvidal采用的影响.
主要方法:
- 采用了定性调查来收集关于英国,芬兰,西班牙和法国Buvidal实施的数据.
- 关键指标包括国家传播率,接受治疗的人口和当前的监管和护理组织系统.
主要成果:
- 在2022年,布维达尔的使用量有显著的变化:英国为2.1%,芬兰为60-65%,西班牙为1%,法国为0.3%.
- 在芬兰和英国,国家卫生系统支付了布维达尔的费用,而西班牙和法国则需要专门的中心来承担费用.
- 西班牙和法国的高基线OAT覆盖率也可能导致观察到的Buvidal使用差异.
结论:
- 在接受OAT的个人中,Buvidal的传播存在重大的国家差异.
- 医疗保健系统结构和报销政策对存储布诺芬治疗的可及性和采用有重大影响.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
157
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
157
Drug Delivery: Enteral Route
417
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
417
Drugs for Treatment of Constipation-Predominant IBS
155
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
155
Drug Control Governance: Regulatory Bodies and Their Impact
150
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
150
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338


